Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,180.74 +52.95 (+1.03%) Dow
38,852.27 +176.59 (+0.46%) Nasdaq
16,349.25 +192.92 (+1.19%) Bitcoin USD
64,091.56 -40.94 (-0.06%) CMC Crypto 200
1,327.06 -38.06 (-2.79%)
Minerva Neurosciences, Inc. (NERV)
After hours:
| Previous close | 2.3700 |
| Open | 2.4100 |
| Bid | 1.6800 x 200 |
| Ask | 3.0200 x 200 |
| Day's range | 2.3400 - 2.4100 |
| 52-week range | 2.2860 - 13.4900 |
| Volume | |
| Avg. volume | 115,161 |
| Market cap | 16.365M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
Minerva Neurosciences (NERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Insider Monkey
12 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023. If you want to skip our introduction to the biotechnology industry and some top players, then check out 5 Best Performing Biotech Stocks in 2023. Biotechnology is one of the hottest industries these days and one that has […]
- Zacks
Here's Why Minerva Neurosciences (NERV) Is a Great 'Buy the Bottom' Stock Now
Minerva Neurosciences (NERV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
